NCT03746925

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

Status unknown NA Last updated 8 August 2022

What this trial tests

NA trial testing Direct Anterior Approach (DAA) in Arthroplasty, Replacement, Hip in 100 participants. Status unknown.

Timeline

7 September 2019

Primary endpoint
7 January 2023

7 April 2023

Quick facts

Lead sponsor	Ottawa Hospital Research Institute
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	7 September 2019
Primary completion	7 January 2023
Estimated completion	7 April 2023
Sites	1 location across Canada

Drugs / interventions tested

• Direct Anterior Approach (DAA)
• SuperPATH

Conditions studied

• Arthroplasty, Replacement, Hip — all drugs for Arthroplasty, Replacement, Hip →

Sponsor

Ottawa Hospital Research Institute

Who can join

Adults 18 to 80, any sex, with Arthroplasty, Replacement, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study involves comparing the outcomes after using the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. These are two approaches to hip replacement that both replace hips without cutting any muscles. DAA approach has been used for many years, but it has a high learning curve and can be difficult for doctors to use, it is however linked with fewer complications when performed by an experienced doctor. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase. It also shows cost-saving results, showing a reduced length of stay for patients and better 30-day readmission rates. There is pressure on surgeons, from both patients and administration to use techniques that spare tissue, offer early functionality without compromising long-term outcomes. The SuperPATH can meet this benchmark but uptake has been slow, the investigators believe that it is due to the learning curve shown by this approach. The senior surgeon at The Ottawa Hospital is experienced in both techniques, using a trial the investigators can compare the two techniques and help encourage surgeons to change to a procedure that has demonstrated a low complication profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.